Literature DB >> 1133518

Proceedings: Effect of a low iodine diet on 131-I therapy in follicular thyroid carcinomata.

B M Goslings.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1133518

Source DB:  PubMed          Journal:  J Endocrinol        ISSN： 0022-0795            Impact factor:   4.286


× No keyword cloud information.
  12 in total

1.  Enhancement of radioiodine uptake in hyperthyroidism by administration of hydrochlorothiazide.

Authors:  Martin A Walter; Egbert U Nitzsche; Jan Müller-Brand
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-01-09       Impact factor: 9.236

Review 2.  ALARA in rhTSH-stimulated post-surgical thyroid remnant ablation: what is the lowest reasonably achievable activity?

Authors:  Daniele Barbaro; Frederik A Verburg; Markus Luster; Christoph Reiners; Domenico Rubello
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-03-20       Impact factor: 9.236

Review 3.  Dietary iodine restriction in preparation for radioactive iodine treatment or scanning in well-differentiated thyroid cancer: a systematic review.

Authors:  Anna M Sawka; Irada Ibrahim-Zada; Philip Galacgac; Richard W Tsang; James D Brierley; Shereen Ezzat; David P Goldstein
Journal:  Thyroid       Date:  2010-10       Impact factor: 6.568

4.  The success rate of initial (131)i ablation in differentiated thyroid cancer: comparison between less strict and very strict low iodine diets.

Authors:  Ik Dong Yoo; Sung Hoon Kim; Ye Young Seo; Jin Kyoung Oh; Joo Hyun O; Soo Kyo Chung
Journal:  Nucl Med Mol Imaging       Date:  2011-10-08

5.  Radioiodine-131 in differentiated thyroid cancer: a retrospective analysis of an uptake-related ablation strategy.

Authors:  Robbert B T Verkooijen; Marcel P M Stokkel; Jan W A Smit; Ernest K J Pauwels
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-01-14       Impact factor: 9.236

6.  Association between excessive urinary iodine excretion and failure of radioactive iodine thyroid ablation in patients with papillary thyroid cancer.

Authors:  Seo Young Sohn; Joon Young Choi; Hye Won Jang; Hye Jeong Kim; Sang Man Jin; Se Won Kim; Sunghwan Suh; Kyu Yeon Hur; Jae Hyeon Kim; Jae Hoon Chung; Sun Wook Kim
Journal:  Thyroid       Date:  2013-06       Impact factor: 6.568

7.  Tumour dosimetry and response in patients with metastatic differentiated thyroid cancer using recombinant human thyrotropin before radioiodine therapy.

Authors:  Bart de Keizer; Boudewijn Brans; Anne Hoekstra; Pierre M J Zelissen; Hans P F Koppeschaar; Cees J M Lips; Peter P van Rijk; Rudi A Dierckx; John M H de Klerk
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-12-19       Impact factor: 9.236

8.  Knowledge, Self-Efficacy, and Perceived Barriers on the Low-Iodine Diet among Thyroid Cancer Patients Preparing for Radioactive Iodine Therapy.

Authors:  Jeong-Ah Moon; Chang-Hee Yoo; Mi Hwa Kim; Song Mi Lee; Young Ja Oh; Young Hoon Ryu; Yong Sang Lee; Hang Seok Chang; Cheong Soo Park; Kyung-Eun Lee
Journal:  Clin Nutr Res       Date:  2012-07-26

Review 9.  Pediatric papillary thyroid cancer: current management challenges.

Authors:  Frederik A Verburg; Hanneke M Van Santen; Markus Luster
Journal:  Onco Targets Ther       Date:  2016-12-28       Impact factor: 4.147

10.  Recommendations for post-surgical thyroid ablation in differentiated thyroid cancer: a 2015 position statement of the Italian Society of Endocrinology.

Authors:  F Pacini; E Brianzoni; C Durante; R Elisei; M Ferdeghini; L Fugazzola; S Mariotti; G Pellegriti
Journal:  J Endocrinol Invest       Date:  2015-08-12       Impact factor: 4.256
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.